FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007232110> ?p ?o ?g. }

• W2007232110 endingPage "1097.e15" @default.
• W2007232110 startingPage "1097.e13" @default.
• W2007232110 abstract "ObjectiveTo report a case of a microprolactinoma in a male-to-female transsexual treated with estrogens and cyproterone acetate.DesignCase report.SettingEndocrinology unit in a university hospital.Patient(s)A 33-year-old male-to-female transsexual with prolactin level of 10 ng/mL.Intervention(s)Treatment with equine-conjugated estrogens (2.5 mg/day, orally) and cyproterone acetate (100 mg/day, orally) during 6 months.Main Outcome Measure(s)Her levels of prolactin were repeatedly found to be elevated to a maximum of 133 ng/mL, and magnetic resonance imaging (MRI) revealed a pituitary mass of 5 × 4 × 4 mm.Result(s)Discontinuation of the cross-sex hormone treatment did not reduce the levels of prolactin. The use of dopaminergic-agonist therapy normalized them and reduced the size of the microadenoma. After sex-reassignment surgery, she was treated with low-dose estradiol transdermal patches and presented normal levels of prolactin and appropriate levels of 17β-estradiol and testosterone with a stable image in MRI.Conclusion(s)We report a case of prolactinoma after treatment with equine-conjugated estrogens and cyproterone acetate. We recommend long-term follow-up observation consisting of a periodic evaluation of prolactin levels and any symptoms suggestive of hyperprolactinemia to detect as early as possible complications derived from cross-sex hormone therapy. To report a case of a microprolactinoma in a male-to-female transsexual treated with estrogens and cyproterone acetate. Case report. Endocrinology unit in a university hospital. A 33-year-old male-to-female transsexual with prolactin level of 10 ng/mL. Treatment with equine-conjugated estrogens (2.5 mg/day, orally) and cyproterone acetate (100 mg/day, orally) during 6 months. Her levels of prolactin were repeatedly found to be elevated to a maximum of 133 ng/mL, and magnetic resonance imaging (MRI) revealed a pituitary mass of 5 × 4 × 4 mm. Discontinuation of the cross-sex hormone treatment did not reduce the levels of prolactin. The use of dopaminergic-agonist therapy normalized them and reduced the size of the microadenoma. After sex-reassignment surgery, she was treated with low-dose estradiol transdermal patches and presented normal levels of prolactin and appropriate levels of 17β-estradiol and testosterone with a stable image in MRI. We report a case of prolactinoma after treatment with equine-conjugated estrogens and cyproterone acetate. We recommend long-term follow-up observation consisting of a periodic evaluation of prolactin levels and any symptoms suggestive of hyperprolactinemia to detect as early as possible complications derived from cross-sex hormone therapy." @default.
• W2007232110 created "2016-06-24" @default.
• W2007232110 creator A5004797265 @default.
• W2007232110 creator A5007959994 @default.
• W2007232110 creator A5032096615 @default.
• W2007232110 creator A5060500684 @default.
• W2007232110 creator A5072778325 @default.
• W2007232110 date "2010-08-01" @default.
• W2007232110 modified "2023-10-17" @default.
• W2007232110 title "Prolactinoma induced by estrogen and cyproterone acetate in a male-to-female transsexual" @default.
• W2007232110 cites W1971658355 @default.
• W2007232110 cites W2021534444 @default.
• W2007232110 cites W2047477014 @default.
• W2007232110 cites W2063732411 @default.
• W2007232110 cites W2071439794 @default.
• W2007232110 cites W2120284109 @default.
• W2007232110 cites W2166539756 @default.
• W2007232110 cites W4249627078 @default.
• W2007232110 doi "https://doi.org/10.1016/j.fertnstert.2010.01.076" @default.
• W2007232110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20227072" @default.
• W2007232110 hasPublicationYear "2010" @default.
• W2007232110 type Work @default.
• W2007232110 sameAs 2007232110 @default.
• W2007232110 citedByCount "38" @default.
• W2007232110 countsByYear W20072321102012 @default.
• W2007232110 countsByYear W20072321102013 @default.
• W2007232110 countsByYear W20072321102014 @default.
• W2007232110 countsByYear W20072321102015 @default.
• W2007232110 countsByYear W20072321102016 @default.
• W2007232110 countsByYear W20072321102017 @default.
• W2007232110 countsByYear W20072321102018 @default.
• W2007232110 countsByYear W20072321102019 @default.
• W2007232110 countsByYear W20072321102020 @default.
• W2007232110 countsByYear W20072321102021 @default.
• W2007232110 countsByYear W20072321102022 @default.
• W2007232110 countsByYear W20072321102023 @default.
• W2007232110 crossrefType "journal-article" @default.
• W2007232110 hasAuthorship W2007232110A5004797265 @default.
• W2007232110 hasAuthorship W2007232110A5007959994 @default.
• W2007232110 hasAuthorship W2007232110A5032096615 @default.
• W2007232110 hasAuthorship W2007232110A5060500684 @default.
• W2007232110 hasAuthorship W2007232110A5072778325 @default.
• W2007232110 hasConcept C11171543 @default.
• W2007232110 hasConcept C126322002 @default.
• W2007232110 hasConcept C134018914 @default.
• W2007232110 hasConcept C15744967 @default.
• W2007232110 hasConcept C2776306840 @default.
• W2007232110 hasConcept C2777155358 @default.
• W2007232110 hasConcept C2777164284 @default.
• W2007232110 hasConcept C2777911890 @default.
• W2007232110 hasConcept C2778918492 @default.
• W2007232110 hasConcept C2779064019 @default.
• W2007232110 hasConcept C2779279991 @default.
• W2007232110 hasConcept C2779671885 @default.
• W2007232110 hasConcept C2780159708 @default.
• W2007232110 hasConcept C2780503580 @default.
• W2007232110 hasConcept C2781401123 @default.
• W2007232110 hasConcept C71315377 @default.
• W2007232110 hasConcept C71924100 @default.
• W2007232110 hasConceptScore W2007232110C11171543 @default.
• W2007232110 hasConceptScore W2007232110C126322002 @default.
• W2007232110 hasConceptScore W2007232110C134018914 @default.
• W2007232110 hasConceptScore W2007232110C15744967 @default.
• W2007232110 hasConceptScore W2007232110C2776306840 @default.
• W2007232110 hasConceptScore W2007232110C2777155358 @default.
• W2007232110 hasConceptScore W2007232110C2777164284 @default.
• W2007232110 hasConceptScore W2007232110C2777911890 @default.
• W2007232110 hasConceptScore W2007232110C2778918492 @default.
• W2007232110 hasConceptScore W2007232110C2779064019 @default.
• W2007232110 hasConceptScore W2007232110C2779279991 @default.
• W2007232110 hasConceptScore W2007232110C2779671885 @default.
• W2007232110 hasConceptScore W2007232110C2780159708 @default.
• W2007232110 hasConceptScore W2007232110C2780503580 @default.
• W2007232110 hasConceptScore W2007232110C2781401123 @default.
• W2007232110 hasConceptScore W2007232110C71315377 @default.
• W2007232110 hasConceptScore W2007232110C71924100 @default.
• W2007232110 hasIssue "3" @default.
• W2007232110 hasLocation W20072321101 @default.
• W2007232110 hasLocation W20072321102 @default.
• W2007232110 hasOpenAccess W2007232110 @default.
• W2007232110 hasPrimaryLocation W20072321101 @default.
• W2007232110 hasRelatedWork W1996607479 @default.
• W2007232110 hasRelatedWork W2002384464 @default.
• W2007232110 hasRelatedWork W2007232110 @default.
• W2007232110 hasRelatedWork W2015609522 @default.
• W2007232110 hasRelatedWork W2035004278 @default.
• W2007232110 hasRelatedWork W2044086047 @default.
• W2007232110 hasRelatedWork W2073158788 @default.
• W2007232110 hasRelatedWork W2079101059 @default.
• W2007232110 hasRelatedWork W2100202028 @default.
• W2007232110 hasRelatedWork W2119381864 @default.
• W2007232110 hasVolume "94" @default.
• W2007232110 isParatext "false" @default.
• W2007232110 isRetracted "false" @default.
• W2007232110 magId "2007232110" @default.
• W2007232110 workType "article" @default.